FUSD:XETRA:XETRA-Fidelity UCITS SICAV - Fidelity US Quality Income UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 9.863

Change

+0.02 (+0.17)%

Market Cap

USD 0.81B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.75 (+1.44%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.25 (+1.48%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.37 (+1.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.38 (+1.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.38%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.74 (+1.90%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.84 (+1.80%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.74 (+1.44%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.61%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.46 (+0.63%)

USD 80.38B

ETFs Containing FUSD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.43% 75% C 74% C
Dividend Return 0.59% 18% F 11% F
Total Return 17.02% 76% C+ 75% C
Trailing 12 Months  
Capital Gain 24.41% 71% C- 71% C-
Dividend Return 1.26% 32% F 22% F
Total Return 25.67% 73% C 73% C
Trailing 5 Years  
Capital Gain 71.00% 80% B- 78% C+
Dividend Return 2.60% 35% F 16% F
Total Return 73.60% 82% B 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 12.07% N/A N/A 76% C+
Dividend Return 12.41% N/A N/A 75% C
Total Return 0.34% N/A N/A 19% F
Risk Return Profile  
Volatility (Standard Deviation) 12.30% N/A N/A 59% D-
Risk Adjusted Return 100.97% N/A N/A 96% N/A
Market Capitalization 0.81B 74% C 65% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike